(Q38197380)

30 August 2017

1 reference

title

Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

30 August 2017

0 references

1 reference

1 reference

Mohamed H Ahmed

1

1 reference

30 August 2017

Asif Ali

series ordinal

2

1 reference

30 August 2017

language of work or name

1 reference

20 March 2014

1 reference

Scandinavian Journal of Gastroenterology

30 August 2017

published in

1 reference

30 August 2017

volume

49

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

521-527

1 reference

The burden of selected digestive diseases in the United States.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gallstone disease: Epidemiology of gallbladder stone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Molecular pathophysiology and physical chemistry of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Lith genes and genetic analysis of cholesterol gallstone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Dissolution of cholesterol gallstones by ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Metabolic disturbances in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gallstone disease is associated with increased mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Fatty liver, carotid disease and gallstones: a study of age-related associations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Current treatment of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Body mass index and waist circumference in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Metabolic syndrome and gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

The metabolic syndrome is associated with complicated gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Presence of gallstones or kidney stones and risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gallbladder disease is associated with insulin resistance in a high risk Hispanic population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Insulin resistance causes human gallbladder dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Hepatic insulin resistance directly promotes formation of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Triglycerides and gallstone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Statin use and risk of gallstone disease followed by cholecystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Cholesterol-rich gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Review article: epidemiology of gall-bladder disease--role of intestinal transit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

The formation of abnormal bile and cholesterol gallstones from dietary cholesterol in the prairie dog

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Long-term statin use and the risk of gallstone disease: A population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Statin administration and risk of cholecystectomy: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.894119

10.3109/00365521.2014.894119

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference